Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS
NCT00586573
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
ADHD
Interventions
DRUG:
memantine hydrochloride
Sponsor
Massachusetts General Hospital